ACS CAN’s Policy Recommendations for Improving Cancer Care in Rural America
People who live in rural and remote areas have specific challenges in accessing cancer treatments and preventive services. It is estimated that up to 20% of the U.S.
Over 130 organizations have endorsed the Clinical Trial Modernization Act (H.R. 3521). The legislation would address known barriers to cancer clinical trial participation, enabling financial and technical support of patients enrolled on trials while protecting them from unexpected tax burdens from that support.